Exhaled 8-isoprostane and prostaglandin E2 in patients with stable and unstable cystic fibrosis{star, open}

Free Radical Biology and Medicine

Volumn 45, Issue 6, 2008, Pages 913-919

  Lucidi, Vincenzina ^a   Ciabattoni, Giovanni ^b   Bella, Sergio ^a   Barnes, Peter J ^c   Montuschi, Paolo ^d  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

8 Isoprostane; Oxidative stress; Prostaglandin E2; Stable cystic fibrosis; Unstable cystic fibrosis

Indexed keywords

8 ISOPROSTANE; C REACTIVE PROTEIN; PROSTAGLANDIN E2;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LUNG FIBROSIS; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

BREATH TESTS; C-REACTIVE PROTEIN; CHILD; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DINOPROST; DINOPROSTONE; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; RESPIRATORY FUNCTION TESTS;

EID: 54949110924     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.06.026     Document Type: Article

References (38)

1. Cantin A.M., White T.B., Cross C.E., Forman H.J., Sokol R.J., and Borowitz D. Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12. Free Radic. Biol. Med. 42 (2007) 15-31
2. O'Malley Y.Q., Reszka K.J., Spitz D.R., Denning G.M., and Britigan B.E. Pseudomonas aeruginosa pyocyanin directly oxidizes glutathione and decreases its levels in airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2004) L94-L103
3. Brown R.K., and Kelly F.J. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr. Res. 36 (1994) 487-493
4. Starosta V., Rietschel E., Paul K., Baumann U., and Griese M. Oxidative changes in bronchoalveolar proteins in cystic fibrosis. Chest 129 (2006) 431-437
5. Witko-Sarasat V., Delacourt C., Rabier D., Bardet J., Nguyen A.T., and Descamp-Latscha B. Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am. J. Respir. Crit. Care Med. 152 (1995) 1910-1916
6. Rosias P.P., Den Hartog G.J., Robroeks C.M., Bast A., Donckerwolcke R.A., Heynens J.W., Suykerbuyk J., Hendriks H.J., Jobsis Q., and Dompeling E. Free radicals in exhaled breath condnesate in cystic fibrosis and healthy subjects. Free Radic. Res. 40 (2006) 901-909
7. Montuschi P. Indirect monitoring of lung inflammation. Nat. Rev. Drug Discov. 1 (2002) 238-242
8. Montuschi P., and Barnes P.J. Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol. Sci. 23 (2002) 232-237
9. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical catalyzed mechanism. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 9383-9387
10. Montuschi P., Barnes P.J., and Roberts L.J. Isoprostanes: markers and mediators of oxidative stress. FASEB J 18 (2004) 1791-1800
11. Morrow J.D. The isoprostanes-unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Curr. Pharm. Des. 12 (2006) 895-902
12. 2a isoprostane in cystic fibrosis. Lipids 34 (1999) 551-556
13. Wood L.G., Fitzgerald D.A., Gibson P.G., Cooper D.M., Collins C.E., and Garg M.L. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J. Am. Coll. Nutr. 20 2 Suppl. (2001) 157-165
14. Ciabattoni G., Davì G., Collura M., Iapichino L., Pardo F., Ganci A., Romagnoli R., Maclouf J., and Patrono C. In vivo lipid peroxidation and platelet activation in cystic fibrosis. Am. J. Respir. Crit. Care Med. 162 (2000) 1195-1201
15. Montuschi P., Kharitonov S.A., Ciabattoni G., Corradi M., van Rensen L., Geddes D.M., Hodson M.E., and Barnes P.J. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 55 (2000) 205-209
16. 2: evidence for a vasodilator effect. J. Appl. Physiol. 64 (1988) 728-741
17. 2. Trends Immunol. 25 (2004) 40-46
18. 2 and increases lymphocytes in cystic fibrosis lungs. Free Radic. Biol. Med. 39 (2005) 463-472
19. Reid D.W., Misso N., Aggarwal S., Thompson P.J., and Walters E.H. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis. Respirology 12 (2007) 63-69
20. Stern R.C. The diagnosis of cystic fibrosis. N. Engl. J. Med. 336 (1997) 487-491
21. Ramsey B.W., Pepe M.S., Quan J.M., Otto K.L., Montgomery A.B., Williams-Warren J., Vasiljev K., Borowitz D., Bowman C.M., Marshall B.C., et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N. Engl. J. Med. 340 (1999) 23-30
22. Shwachman H., and Kulczycki L.L. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J. Dis. Child 96 (1958) 6-15
23. Chrispin A.R., and Norman A.P. The systematic evaluation of the chest radiograph with cystic fibrosis. Pediatr. Radiol. 2 (1974) 101-105
24. Montuschi P., Varone F., Valente S., Spina D., Mondino C., Ciappi G., and Ciabattoni G. Methodological aspects of exhaled prostanoid measurements. Eur. Respir. J. 22 Suppl. 54 (2003) 18s
25. Montuschi P., and Barnes P.J. Exhaled leukotrienes and prostaglandins in asthma. J. Allergy Clin. Immunol. 109 (2002) 615-620
26. 2a excretion in man. J. Pharmacol. Exp. Ther. 275 (1995) 94-100
27. 2 measurements in exhaled breath condensate. Inflamm. Res. 52 (2003) 502-506
28. Montuschi P., Barnes P.J., and Roberts L.J. Insights into oxidative stress: the isoprostanes. Curr. Med. Chem. 14 (2007) 703-717
29. Montuschi P. Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther. Adv. Respir. Med. 1 (2007) 5-23
30. Wood L.G., Fitzgerald D.A., Gibson P.G., Cooper D.M., and Garg M.L. Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients. Am. J. Clin. Nutr. 75 (2002) 668-675
31. 2a induces airflow obstruction and airway plasma exudation in vivo. Am. J. Respir. Crit. Care Med. 155 (1997) 436-441
32. 2a in isolated perfused rat lung. J. Appl. Physiol. 74 (1993) 460-465
33. 4 markedly elevated in epithelial lining fluid of patients with cystic fibrosis. Am. Rev. Respir. Dis. 148 (1993) 896-901
34. Strandvik B., Svensson E., and Seyberth H.W. Prostanoid biosynthesis in patients with cystic fibrosis. Prostaglandins Leukot. Essent. Fatty Acids 55 (1996) 419-425
35. 2 expression by pulmonary epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 289 (2005) L816-L824
36. Zamamiri-Davis F., Lu Y., Thompson J.T., Prabhu K.S., Reddy P.V., Sordillo L.M., and Reddy C.C. Nuclear factor-kappaB mediates over-expression of cyclooxygenase-2 during activation of RAW 264.7 macrophages in selenium deficiency. Free Radic. Biol. Med. 32 (2002) 890-897
37. Vij N., Amoako M.O., Mazur S., and Zeitlin P.L. CHOP transcription factor mediates IL-8 signaling in cystic fibrosis bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 38 (2008) 176-184
38. Nakamura H., Yoshimura K., McElvaney N.G., and Crystal R.G. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J. Clin. Invest. 89 (1992) 1478-1484